Cannabinoid receptor 1

Cannabinoid Receptor 1

In situ hybridization of CNR1 in mouse brain

Cannabinoid Receptor 1 (CB1) is a G protein-coupled receptor (GPCR) that is primarily found in the central nervous system (CNS) and is one of the two main receptors for cannabinoids, the other being Cannabinoid Receptor 2 (CB2). CB1 receptors are involved in a variety of physiological processes including appetite, pain sensation, mood, and memory.

Structure

CB1 is a member of the GPCR family, characterized by seven transmembrane domains. The receptor is encoded by the CNR1 gene in humans. The structure of CB1 allows it to interact with various ligands, including endogenous cannabinoids like anandamide and 2-arachidonoylglycerol (2-AG), as well as exogenous cannabinoids such as tetrahydrocannabinol (THC), the psychoactive component of cannabis.

Distribution

CB1 receptors are predominantly located in the brain, with high concentrations in the cerebral cortex, hippocampus, basal ganglia, and cerebellum. They are also found in peripheral tissues, albeit in lower densities. The distribution of CB1 receptors correlates with their role in modulating neurotransmitter release and influencing various neural circuits.

Function

CB1 receptors play a crucial role in the endocannabinoid system, which is involved in maintaining homeostasis within the body. Activation of CB1 receptors by cannabinoids leads to the inhibition of adenylate cyclase, reduction of cyclic AMP levels, and modulation of ion channels. This results in decreased release of neurotransmitters such as glutamate, GABA, and dopamine, affecting processes like pain modulation, appetite regulation, and memory formation.

Clinical Significance

CB1 receptors are implicated in various neurological disorders and conditions. They are a target for therapeutic interventions in chronic pain, epilepsy, and multiple sclerosis. The psychoactive effects of cannabis are primarily mediated through CB1 receptor activation. Antagonists of CB1 receptors have been explored for the treatment of obesity and metabolic disorders, although some have been withdrawn due to adverse psychiatric effects.

Research

Ongoing research is focused on understanding the precise mechanisms of CB1 receptor signaling and its role in neuroprotection, neurodegeneration, and psychiatric disorders. The development of selective CB1 receptor modulators holds promise for new therapeutic strategies.

Related pages

• Cannabinoid receptor
• Cannabinoid Receptor 2
• Endocannabinoid system
• Tetrahydrocannabinol
• Anandamide